Dashboard
Manage Tickers

CNMD CONMED Corp

NYSE conmed.com


$ 48.36 $ 0.59 (1.23 %)    

Tuesday, 21-Oct-2025 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 610.29 $ -0.16 (-0.03 %)
DIA $ 469.10 $ 2.20 (0.47 %)
SPY $ 670.98 $ -0.01 (0 %)
TLT $ 91.99 $ 0.45 (0.49 %)
GLD $ 376.61 $ -25.91 (-6.43 %)
$ 48.37
$ 47.83
$ 47.00 x 1
$ 48.92 x 1
$ 47.63 - $ 48.88
$ 42.50 - $ 76.94
374,342
na
1.5B
$ 1.01
$ 13.59
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-18-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 04-25-2024 03-31-2024 10-Q
7 02-28-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 07-27-2023 06-30-2023 10-Q
10 04-27-2023 03-31-2023 10-Q
11 02-21-2023 12-31-2022 10-K
12 10-27-2022 09-30-2022 10-Q
13 07-28-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 07-29-2021 06-30-2021 10-Q
18 04-29-2021 03-31-2021 10-Q
19 02-22-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 04-30-2020 03-31-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-31-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 04-26-2019 03-31-2019 10-Q
27 02-25-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 04-26-2018 03-31-2018 10-Q
31 02-26-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 07-27-2017 06-30-2017 10-Q
34 04-27-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 10-28-2016 09-30-2016 10-Q
37 07-28-2016 06-30-2016 10-Q
38 05-02-2016 03-31-2016 10-Q
39 02-23-2016 12-31-2015 10-K
40 10-23-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

piper-sandler-maintains-overweight-on-conmed-lowers-price-target-to-68
Piper Sandler Maintains Overweight on Conm...
07/31/2025 13:55:51

Piper Sandler analyst Matt O'Brien maintains Conmed (NYSE:CNMD) with a Overweight and lowers the price target from $80 t...

conmed-lowers-fy2025-adj-eps-guidance-from-445-460-to-440-455-vs-439-est-raises-fy2025-sales-guidance-from-1350b-1378b-to-1356b-1378b-vs-1362b-est
Conmed Lowers FY2025 Adj EPS Guidance from...
07/30/2025 21:05:34

Conmed (NYSE:CNMD) lowers FY2025 Adj EPS guidance from $4.45-$4.60 to $4.40-$4.55 vs $4.39 analyst estimate. Raises FY2025 sale...

conmed-q2-adj-eps-115-beats-112-estimate-sales-342345m-beat-338167m-estimate
Conmed Q2 Adj. EPS $1.15 Beats $1.12 Estim...
07/30/2025 20:06:39

Conmed (NYSE:CNMD) reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.12 by 2.4 per...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

merit-medical-names-medtronic-veteran-martha-aronson-as-next-ceo-projects-strong-outlook
Merit Medical Names Medtronic Veteran Mart...
07/08/2025 12:34:54

Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates.

this-conagra-brands-analyst-turns-bearish-here-are-top-3-downgrades-for-thursday
This Conagra Brands Analyst Turns Bearish;...
06/12/2025 13:10:43

demystifying-conmed-insights-from-5-analyst-reviews
Demystifying Conmed: Insights From 5 Analy...
06/12/2025 13:00:48

needham-downgrades-conmed-to-hold-maintains-price-target-to-61
Needham Downgrades Conmed to Hold, Maintai...
06/12/2025 12:32:17

Needham analyst Mike Matson downgrades Conmed (NYSE:CNMD) from Buy to Hold and maintains the price target from $61 to $61.

conmed-appoints-laverne-council-to-succeed-martha-goldberg-aronson-as-independent-chair-of-the-board-of-directors-effective-may-21-2025
CONMED Appoints Laverne Council To Succeed...
05/21/2025 11:17:53

jp-morgan-maintains-neutral-on-conmed-lowers-price-target-to-58
JP Morgan Maintains Neutral on Conmed, Low...
05/01/2025 17:47:44

JP Morgan analyst Robbie Marcus maintains Conmed (NYSE:CNMD) with a Neutral and lowers the price target from $70 to $58.

cvs-health-posts-better-than-expected-earnings-joins-commscope-microsoft-meta-chart-industries-and-other-big-stocks-moving-higher-on-thursday
CVS Health Posts Better-Than-Expected Earn...
05/01/2025 15:36:36

wells-fargo-maintains-equal-weight-on-conmed-lowers-price-target-to-57
Wells Fargo Maintains Equal-Weight on Conm...
05/01/2025 15:28:35

Wells Fargo analyst Vik Chopra maintains Conmed (NYSE:CNMD) with a Equal-Weight and lowers the price target from $70 to $57.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/01/2025 12:05:58

breaking-down-conmed-6-analysts-share-their-views
Breaking Down Conmed: 6 Analysts Share The...
05/01/2025 12:00:33

needham-maintains-buy-on-conmed-lowers-price-target-to-61
Needham Maintains Buy on Conmed, Lowers Pr...
05/01/2025 11:59:05

Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and lowers the price target from $91 to $61.

correction-conmed-q1-adj-eps-095-beats-081-estimate-sales-32130m-beat-31337m-estimate
CORRECTION: Conmed Q1 Adj. EPS $0.95 Beats...
04/30/2025 22:17:19

Conmed (NYSE:CNMD) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of $0.81 by 17.28 p...

conmed-raises-fy2025-adj-eps-guidance-from-425-440-to-445-460-vs-434-est-raises-fy2025-sales-guidance-from-134b-137b-to-135b-138b-vs-136b-est
Conmed Raises FY2025 Adj EPS Guidance from...
04/30/2025 20:23:42

Conmed (NYSE:CNMD) raises FY2025 Adj EPS guidance from $4.25-$4.40 to $4.45-$4.60 vs $4.34 analyst estimate. Raises FY2025 sale...

Core News & Articles
Earnings Scheduled For April 30, 2025
04/30/2025 08:32:41

stifel-downgrades-conmed-to-hold-lowers-price-target-to-55
Stifel Downgrades Conmed to Hold, Lowers P...
04/28/2025 15:04:30

Stifel analyst Rick Wise downgrades Conmed (NYSE:CNMD) from Buy to Hold and lowers the price target from $75 to $55.

breaking-down-conmed-4-analysts-share-their-views
Breaking Down Conmed: 4 Analysts Share The...
02/06/2025 21:00:19

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION